兴奋性氨基酸递质系统在乐果诱导星形胶质细胞活化中的作用

目的 探讨兴奋性氨基酸递质系统在乐果染毒后皮层星形胶质细胞活化中的作用.方法 新生大鼠皮层神经细胞传代3次后获得纯化的星形胶质细胞,分别加入终浓度为10-6、10-5、10-4mol/[的乐果,并用50和100 μmol/LN-甲基-N-天门冬氨酸(NMDA)受体非竞争性拮抗剂MK801对10-4mol/L乐果染毒组进行干预.染毒后48 h收获细胞,高效液相色谱-荧光检测系统(HPLC-FLD)方法测定细胞内兴奋性氨基酸递质含量,反转录聚合酶链反应(RT-PCR)法检测NMDA受体NR2B亚基、谷氨酸(Glu)、谷氨酸转运体(GLT-1)、天冬氨酸(Asp)、谷氨酸/天冬氨酸转运体(GLAST)、胶质纤维酸性蛋白(GFAP)及S100β mRNA表达的变化,免疫荧光染色半定量检测GFAP以及S100β的蛋白表达.结果 各剂量染毒组GLASTmRNA表达下降为对照组的67.8%、68.6%和76.2%,差异有统计学意义(P＜0.05);10-4 mol/L染毒组Glu、Asp含量与对照组相比明显下降,差异有统计学意义(P＜0.01);与对照组比较,10-4mol/L染毒组GFAP和10-5mol/L染毒组S100βmRNA表达,10-5、10-4mol/L染毒组GFAP蛋白表达,10-4mol/L染毒组S100β蛋白表达明显上升,差异有统计学意义(P＜0.01),有剂量依赖趋势.对10-4mol/L染毒组给予50和100 μmol/L MK801干预后,GLT-1、GLAST mRNA表达水平较10-4 mol/L染毒组明显上升,差异有统计学意义(P＜0.01),NR2B mRNA表达进一步升高,与未干预前相比,差异无统计学意义(P＞0.05),但均明显高于对照组水平,差异有统计学意义(P＜0.05,P＜0.01);100 μmol/L MK801干预后,Glu的含量升高为10-4mol/L染毒组的1.81倍,差异有统计学意义(P＜0.01);50和100μmol/LMK801干预后,GFAP转录及蛋白水平较未干预前明显下降,差异有统计学意义(P＜0.01),50 μmol/L干预组S100β蛋白表达水平仍然高于对照组,差异有统计学意义(P＜0.01).结论 乐果对兴奋性氨基酸递质系统的影响参与了星形胶质细胞的活化;NMDA受体阻断剂MK801有助于控制星形胶质细胞胶质化.

Abstract：

Objective To study the involvement of excitatory amino acid system in astrocytes activation caused by dimethoate. Methods Pure-cultured astrocytes were gained by three passages from primary cultured rat nerve cells, then treated with 10-6,10-5,10-4 mol/L dimethoate for 48 h, 50 μmol/L and 100μmol/L MK801, a NMDA receptor blocker, was used to intervene the effects induced by 10-4 mol/L dimethoate.HPLC-FLD was utilized to measure the concentrations of excitatory amino acid (EAA), RT-PCR was used to detect the expression levels of NR2B, GLT-1, GLAST, GFAP and S100β mRNA, and immunofluresence staining method was applied to measure the expression levels of GFAP and S100β proteins. Results The expression levels of GLAST mRNA in all exposure groups were 67.8% ,68.6% and 76.2% of control level,respectively, which were significantly lower than that of control group (P＜0.05); The concentrations of EAA significantly decreased in 10-4 mol/L dimethoate group, as compared with control group (P＜0.01); the expression levels of GFAP mRNA in 10-4 mol/L dimethoate group, of S100β mRNA in 10-5 mol/L dimethoate group, of GFAP protein in 10-4 mol/L and 10-5 mol/L dimethoate groups and S100β protein in 10-4 mol/L dimethoate group were significantly higher than those in control group (P＜0.01). The expression levels of GLT-1 and GLAST mRNA in 10-4 mol/L dimethoate plus 50 μ mol/L or 100 μ mol/L MK801 groups increased significantly, as compared with 10-4 mol/L dimethoate group (P＜0.01), the expression levels of NR2B mRNA in 10-4 mol/L dimethoate plus 50 μ mol/L or 100 μmol/L MK801 groups increased significantly, as compared with control group (P＜0.05 or P＜0.01); the concentration of Glu in 10-4 mol/L dimethoate plus 100 μ mol/L MK801 group increased significantly, as compared with 10-4 mol/L dimethoate group (P＜0.01); the expression levels of GFAP mRNA and protein in10-4 mol/L dimethoate plus 50 μ mol/L or 100 μ mol/L MK801 groups decreased significantly (P＜0.01); S100β protein expression level in 50 μ mol/L MK801 intervention group was significantly higher than thatl in control group (P＜0.01). Conclusion Excitatory amino acid system involved in astrocytes activation caused by dimethoate. MK801 was useful to control astrocytes gliosis.

Involvement of excitatory amino acid system in astrocytes activation caused by dimethoate

Objective To study the involvement of excitatory amino acid system in astrocytes activation caused by dimethoate. Methods Pure-cultured astrocytes were gained by three passages from primary cultured rat nerve cells, then treated with 10-6,10-5,10-4 mol/L dimethoate for 48 h, 50 μmol/L and 100μmol/L MK801, a NMDA receptor blocker, was used to intervene the effects induced by 10-4 mol/L dimethoate.HPLC-FLD was utilized to measure the concentrations of excitatory amino acid (EAA), RT-PCR was used to detect the expression levels of NR2B, GLT-1, GLAST, GFAP and S100β mRNA, and immunofluresence staining method was applied to measure the expression levels of GFAP and S100β proteins. Results The expression levels of GLAST mRNA in all exposure groups were 67.8% ,68.6% and 76.2% of control level,respectively, which were significantly lower than that of control group (P＜0.05); The concentrations of EAA significantly decreased in 10-4 mol/L dimethoate group, as compared with control group (P＜0.01); the expression levels of GFAP mRNA in 10-4 mol/L dimethoate group, of S100β mRNA in 10-5 mol/L dimethoate group, of GFAP protein in 10-4 mol/L and 10-5 mol/L dimethoate groups and S100β protein in 10-4 mol/L dimethoate group were significantly higher than those in control group (P＜0.01). The expression levels of GLT-1 and GLAST mRNA in 10-4 mol/L dimethoate plus 50 μ mol/L or 100 μ mol/L MK801 groups increased significantly, as compared with 10-4 mol/L dimethoate group (P＜0.01), the expression levels of NR2B mRNA in 10-4 mol/L dimethoate plus 50 μ mol/L or 100 μmol/L MK801 groups increased significantly, as compared with control group (P＜0.05 or P＜0.01); the concentration of Glu in 10-4 mol/L dimethoate plus 100 μ mol/L MK801 group increased significantly, as compared with 10-4 mol/L dimethoate group (P＜0.01); the expression levels of GFAP mRNA and protein in10-4 mol/L dimethoate plus 50 μ mol/L or 100 μ mol/L MK801 groups decreased significantly (P＜0.01); S100β protein expression level in 50 μ mol/L MK801 intervention group was significantly higher than thatl in control group (P＜0.01). Conclusion Excitatory amino acid system involved in astrocytes activation caused by dimethoate. MK801 was useful to control astrocytes gliosis.